Metabolism of proteoglycans in tendon

Scandinavian Journal of Medicine and Science in Sports

Volumn 19, Issue 4, 2009, Pages 470-478

  Rees, S G ^a   Dent, C M ^b   Caterson, B ^c  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ADAMTS; Aggrecan; Aggrecanase; SLRPs; Tendinopathy

Indexed keywords

PROTEOGLYCAN;

EXTRACELLULAR MATRIX; FIBROCARTILAGE; HUMAN; MECHANICAL STRESS; METABOLISM; REVIEW; TENDINITIS; TENDON;

EXTRACELLULAR MATRIX; FIBROCARTILAGE; HUMANS; PROTEOGLYCANS; STRESS, MECHANICAL; TENDINOPATHY; TENDONS;

EID: 69149091670     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2009.00938.x     Document Type: Review

References (86)

1. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. Faseb J 2002 : 16 : 673 680.
2. Aspberg A, Adam S, Kostka G, Timpl R, Heinegard D. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem 1999 : 274 : 20444 20449.
3. Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001 : 199 : 503 526.
4. Berenson MC, Blevins FT, Plaas AH, Vogel KG. Proteoglycans of human rotator cuff tendons. J Orthop Res 1996 : 14 : 518 525.
5. Campbell MA, Winter AD, Ilic MZ, Handley CJ. Catabolism and loss of proteoglycans from cultures of bovine collateral ligament. Arch Biochem Biophys 1996 : 328 : 64 72.
6. Carrino DA, Onnerfjord P, Sandy JD, Cs-Szabo G, Scott PG, Sorrell JM, Heinegard D, Caplan AI. Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem 2003 : 278 : 17566 17572.
7. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998 : 141 : 1277 1286.
8. Chard MD, Cawston TE, Riley GP, Gresham GA, Hazleman BL. Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis 1994 : 53 : 30 34.
9. Chockalingam PS, Zeng W, Morris EA, Flannery CR. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2). Arthritis Rheum 2004 : 50 : 2839 2848.
10. Corps AN, Robinson AH, Movin T, Costa ML, Hazleman BL, Riley GP. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 2006 : 45 : 291 294.
11. Corps AN, Robinson AH, Movin T, Costa ML, Ireland DC, Hazleman BL, Riley GP. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology (Oxford) 2004 : 43 : 969 972.
12. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997 : 136 : 729 743.
13. Day JM, Olin AI, Murdoch AD, Canfield A, Sasaki T, Timpl R, Hardingham TE, Aspberg A. Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem 2004 : 279 : 12511 12518.
14. Drummond AH, Beckett P, Brown PD, Bone EA, Davidson AH, Galloway WA, Gearing AJ, Huxley P, Laber D, McCourt M, Whittaker M, Wood LM, Wright A. Preclinical and clinical studies of MMP inhibitors in cancer. Ann NY Acad Sci 1999 : 878 : 228 235.
15. Evanko SP, Vogel KG. Proteoglycan synthesis in fetal tendon is differentially regulated by cyclic compression in vitro. Arch Biochem Biophys 1993 : 307 : 153 164.
16. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986 : 883 : 173 177.
17. Flannery CR, Hughes CE, Schumacher BL, Tudor D, Aydelotte MB, Kuettner KE, Caterson B. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun 1999 : 254 : 535 541.
18. Gillard GC, Merrilees MJ, Bell-Booth PG, Reilly HC, Flint MH. The proteoglycan content and the axial periodicity of collagen in tendon. Biochem J 1977 : 163 : 145 151.
19. Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett 2001 : 494 : 192 195.
20. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998 : 17 : 1 19.
21. Hutchinson JW, Tierney GM, Parsons SL, Davis TR. Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor. J Bone Joint Surg Br 1998 : 80 : 907 908.
22. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998 : 67 : 609 652.
23. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999 : 274 : 18843 18846.
24. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, Chakravarti S. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem 2002 : 277 : 35532 35540.
25. Jones GC, Corps AN, Pennington CJ, Clark IM, Edwards DR, Bradley MM, Hazleman BL, Riley GP. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum 2006 : 54 : 832 842.
26. Jones L, Ghaneh P, Humphreys M, Neoptolemos JP. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann NY Acad Sci 1999 : 880 : 288 307.
27. Kannus P. Tendons - a source of major concern in competitive and recreational athletes. Scand J Med Sci Sports 1997 : 7 : 53 54.
28. Kannus P, Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am 1991 : 73 : 1507 1525.
29. Kannus P, Paavola M, Jozsa L. Aging and degeneration of tendons. In : Maffulli N, Renstrom P, Leadbetter WB, eds. Tendon injuries. Berlin : Springer, 2005 : 25 31.
30. Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y, Nagase H. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004 : 279 : 10109 10119.
31. Kashiwagi M, Tortorella M, Nagase H, Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 2001 : 276 : 12501 12504.
32. Linsenmayer TF, Fitch JM, Birk DE. Heterotypic collagen fibrils and stabilizing collagens. Controlling elements in corneal morphogenesis? Ann NY Acad Sci 1990 : 580 : 143 160.
33. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999 : 344 : 61 68.
34. Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, Taiwo YO, Mitchell PG, Otterness IG, Flannery CR, Caterson B. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol 2002 : 21 : 271 288.
35. Liu CY, Birk DE, Hassell JR, Kane B, Kao WW. Keratocan-deficient mice display alterations in corneal structure. J Biol Chem 2003 : 278 : 21672 21677.
36. Marcelino J, Carpten JD, Suwairi WM, Gutierrez OM, Schwartz S, Robbins C, Sood R, Makalowska I, Baxevanis A, Johnstone B, Laxer RM, Zemel L, Kim CA, Herd JK, Ihle J, Williams C, Johnson M, Raman V, Alonso LG, Brunoni D, Gerstein A, Papadopoulos N, Bahabri SA, Trent JM, Warman ML. CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet 1999 : 23 : 319 322.
37. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000 : 6 : 149 156.
38. Melching LI, Fisher WD, Lee ER, Mort JS, Roughley PJ. The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage 2006 : 14 : 1147 1154.
39. Milgrom C, Schaffler M, Gilbert S, van Holsbeeck M. Rotator-cuff changes in asymptomatic adults. The effect of age, hand dominance and gender. J Bone Joint Surg Br 1995 : 77 : 296 298.
40. Monfort J, Tardif G, Roughley P, Reboul P, Boileau C, Bishop PN, Pelletier JP, Martel-Pelletier J. Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis. Osteoarthritis Cartilage 2008 : 16 : 749 755.
41. Munteanu SE, Ilic MZ, Handley CJ. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures. Matrix Biol 2002 : 21 : 429 440.
42. Ochi T, Iwase R, Okabe N, Fink CW, Ono K. The pathology of the involved tendons in patients with familial arthropathy and congenital camptodactyly. Arthritis Rheum 1983 : 26 : 896 900.
43. Olin AI, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A. The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 2001 : 276 : 1253 1261.
44. Poon CJ, Plaas AH, Keene DR, McQuillan DJ, Last K, Fosang AJ. N-linked keratan sulfate in the aggrecan interglobular domain potentiates aggrecanase activity. J Biol Chem 2005 : 280 : 23615 23621.
45. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J 2005 : 386 : 15 27.
46. Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res 1993 : 56 : 635 648.
47. Ralphs JR, Benjamin M, Thornett A. Cell and matrix biology of the suprapatella in the rat: a structural and immunocytochemical study of fibrocartilage in a tendon subject to compression. Anat Rec 1991 : 231 : 167 177.
48. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology (Oxford) 2006 : 45 : 508 521.
49. Rees SG, Curtis CL, Dent CM, Caterson B. Catabolism of aggrecan proteoglycan aggregate components in short-term explant cultures of tendon. Matrix Biol 2005 : 24 : 219 231.
50. Rees SG, Davies JR, Tudor D, Flannery CR, Hughes CE, Dent CM, Caterson B. Immunolocalisation and expression of proteoglycan 4 (cartilage superficial zone proteoglycan) in tendon. Matrix Biol 2002 : 21 : 593 602.
51. Rees SG, Flannery CR, Little CB, Hughes CE, Caterson B, Dent CM. Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J 2000 : 350 : 181 188.
52. Rees SG, Waggett AD, Dent CM, Caterson B. Inhibition of aggrecan turnover in short-term explant cultures of bovine tendon. Matrix Biol 2007 : 26 : 280 290.
53. Rees SG, Waggett AD, Kerr BC, Probert J, Gealy EC, Dent CM, Caterson B, Hughes CE. Immunolocalisation and expression of keratocan in tendon. Osteoarthritis Cartilage 2008 : 17 : 276 279.
54. Renstrom PA, Hach T. Insertional tendinopathy in sport. In : Maffulli N, Renstrom P, Leadbetter WB, eds. Tendon injuries. Berlin : Springer, 2005 : 70 85.
55. Renstrom PA, Woo SL-Y. Tendinopathy: a major medical problem in sport. In : Woo SL-Y, Renstrom PA, Arnoczky SP, eds. Tendinopathy in athletes. Blackwell Publishing, Massachusetts, USA, 2008 : 1 9.
56. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005 : 115 : 622 631.
57. Riley G. Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev Mol Med 2005 : 7 : 1 25.
58. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE, Hazleman BL. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Annu Rheum Dis 1994 : 53 : 367 376.
59. Robbins JR, Vogel KG. Regional expression of mRNA for proteoglycans and collagen in tendon. Eur J Cell Biol 1994 : 64 : 264 270.
60. Samiric T, Ilic MZ, Handley CJ. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 2004a : 23 : 127 140.
61. Samiric T, Ilic MZ, Handley CJ. Large aggregating and small leucine-rich proteoglycans are degraded by different pathways and at different rates in tendon. Eur J Biochem 2004b : 271 : 3612 3620.
62. Schumacher BL, Block JA, Schmid TM, Aydelotte MB, Kuettner KE. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys 1994 : 311 : 144 152.
63. Smith MM, Sakurai G, Smith SM, Young AA, Melrose J, Stewart CM, Appleyard RC, Peterson JL, Gillies RM, Dart AJ, Sonnabend DH, Little CB. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain. Arthritis Rheum 2008 : 58 : 1055 1066.
64. Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 1999 : 274 : 9636 9647.
65. Swann DA, Hendren RB, Radin EL, Sotman SL, Duda EA. The lubricating activity of synovial fluid glycoproteins. Arthritis Rheum 1981 : 24 : 22 30.
66. Swann DA, Silver FH, Slayter HS, Stafford W, Shore E. The molecular structure and lubricating activity of lubricin isolated from bovine and human synovial fluids. Biochem J 1985 : 225 : 195 201.
67. Sztrolovics R, Recklies AD, Roughley PJ, Mort JS. Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1beta-stimulated catabolism. Biochem J 2002 : 362 : 473 479.
68. Sztrolovics R, White RJ, Poole AR, Mort JS, Roughley PJ. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J 1999 : 339 : 571 577.
69. Tierney GM, Griffin NR, Stuart RC, Kasem H, Lynch KP, Lury JT, Brown PD, Millar AW, Steele RJ, Parsons SL. A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer. Eur J Cancer 1999 : 35 : 563 568.
70. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 2003 : 21 : 256 264.
71. Vogel KG. The effect of compressive loading on proteoglycan turnover in cultured fetal tendon. Connect Tissue Res 1996 : 34 : 227 237.
72. Vogel KG. What happens when tendons bend and twist? Proteoglycans. J Musculoskelet Neuronal Interact 2004 : 4 : 202 203.
73. Vogel KG, Evanko S, Robbins JR. What proteoglycan content says about the mechanical history of tendon. In : Archer CW, Caterson B, Benjamin M, Ralphs JR, eds. Biology of the synovial joint. Harwood Academic Publishers, Amsterdam, the Netherlands, 1999 : 301 313.
74. Vogel KG, Evanko SP. Proteoglycans of fetal bovine tendon. J Biol Chem 1987 : 262 : 13607 13613.
75. Vogel KG, Heinegard D. Characterization of proteoglycans from adult bovine tendon. J Biol Chem 1985 : 260 : 9298 9306.
76. Vogel KG, Koob TJ. Structural specialization in tendons under compression. Int Rev Cytol 1989 : 115 : 267 293.
77. Vogel KG, Ordog A, Pogany G, Olah J. Proteoglycans in the compressed region of human tibialis posterior tendon and in ligaments. J Orthop Res 1993 : 11 : 68 77.
78. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984 : 223 : 587 597.
79. Vogel KG, Peters JA. Histochemistry defines a proteoglycan-rich layer in bovine flexor tendon subjected to bending. J Musculoskelet Neuronal Interact 2005 : 5 : 64 69.
80. Vogel KG, Sandy JD, Pogany G, Robbins JR. Aggrecan in bovine tendon. Matrix Biol 1994 : 14 : 171 179.
81. Waggett AD, Ralphs JR, Kwan AP, Woodnutt D, Benjamin M. Characterization of collagens and proteoglycans at the insertion of the human Achilles tendon. Matrix Biol 1998 : 16 : 457 470.
82. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002 : 14 : 617 623.
83. Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ. Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol 1998 : 16 : 2150 2156.
84. Xu JH, Radhakrishnamurthy B, Srinivasan SR, Berenson GS. Primary structure of bovine aorta biglycan core protein deduced from cloned CDNA. Biochem Mol Biol Int 1995 : 37 : 263 272.
85. Young MF, Bi Y, Ameye L, Chen XD. Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 2002 : 19 : 257 262.
86. Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000 : 275 : 31226 31232.